Company profile · federal money
Revagenix Inc
Revagenix Inc received $14.23M in federal awards in FY2026 (up 2021% from FY2025). It ranks #3622 among federal contractors. Largest customer: Department of Health and Human Services ($14.23M). Main industries: Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology).
- FY2026 federal obligations
- $14.23M
- FY2025
- $670.8K
- Rank among contractors
- #3622
Largest customers: Department of Health and Human Services $14.23M
By fiscal year: FY2023 $5.12M · FY2024 $17.91M · FY2025 $670.8K · FY2026 $14.23M
Industries (NAICS): Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) $14.23M
Where the work is done: California $14.23M
Largest awards in FY2026:
- 75N93022C00061 $12.10M from Department of Health and Human Services: Eo14398 a Novel LPXC Inhibitor With Pan-Resistant Pseudomonas and Burkholderia Activity.
- 75N93020C00018 $2.13M from Department of Health and Human Services: To Select a Novel Small Molecule Antibiotic for Clinical Development and Advance IT Through Ind Filing and Phase 1 Clinical Studies.
Data through 2026-10-19; source: USAspending.gov.
Gathering everything on record…
From public government records, which may contain errors. Check the official source before relying on a number. Not financial, legal or investment advice. Terms · About the data